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Abstract 
Background: Despite the prevalence of CDH23 mutations in East Asians, its large size hinders investigation. The path‑
ologic mutation p.P240L in CDH23 is common in East Asians. However, whether this mutation represents a common 
founder or a mutational hot spot is unclear. The prevalence of CDH23 mutations with prelingual severe‑to‑profound 
sporadic or autosomal recessive sensorineural hearing loss (arSNHL) is unknown in Koreans.
Methods: From September 2010 to October 2014, children with severe‑to‑profound sporadic or arSNHL without 
phenotypic markers, and their families, were tested for mutations in connexins GJB2, GJB6 and GJB3. Sanger sequenc‑
ing of CDH23 p.P240L was performed on connexin‑negative samples without enlarged vestibular aqueducts (EVA), 
followed by targeted resequencing of 129 deafness genes, including CDH23, unless p.P240L homozygotes were 
detected in the first screening. Four p.P240L‑allele‑linked STR markers were genotyped in 40 normal‑hearing control 
subjects, and the p.P240L carriers in the hearing‑impaired cohort, to identify the haplotypes.
Results: Four (3.1 %) of 128 children carried two CDH23 mutant alleles, and SLC26A4 and GJB2 accounted for 18.0 and 
17.2 %, respectively. All four children showed profound nonsyndromic SNHL with minimal residual hearing. Interest‑
ingly, all had at least one p.P240L mutant allele. Analysis of p.P240L‑linked STR markers in these children and other 
postlingual hearing‑impaired adults carrying p.P240L revealed that p.P240L was mainly carried on a single haplotype.
Conclusions: p.P240L contributed significantly to Korean pediatric severe arSNHL with a strong founder effect, with 
implications for future phylogenetic studies. Screening for p.P240L as a first step in GJB2‑negative arSNHL Koreans 
without EVA is recommended.
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Background
Many loci can cause genetic sensorineural hearing loss 
(SNHL), which accounts for more than 50 % of SNHL [1]. 
New molecular genetic techniques, such as whole-exome 
sequencing [2] and targeted resequencing (TRS) [3], have 
enabled more in-depth understanding of the molecular 
etiologies of SNHL. These next-generation sequencing 
(NGS) technologies have assisted in screening of large 
deafness genes.
CDH23 (NM_022124) is a prime example as this gene 
consists of 69 exons, 11,073 bases, and is located on 
chromosome 10q21–q22 [4–7]. It encodes cadherin 23, 
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consisting of 3,354 amino acids and forms 27 extracel-
lular domains (EC), a single transmembrane domain and 
a short cytoplasmic domain. This protein is reported 
to contribute to tip link formation by interacting 
with protocadherin 15 which is encoded by PCDH15 
(NM_001142771). It thereby maintains the structural 
integrity of the tip link and the mechanoelectrical trans-
ducer currents of hair cells [8, 9]. Mutations in CDH23 
lead to two types of phenotypic disorder or nonsense, 
splice-site, frameshift mutations, which are assumed 
to severely disrupt the functions of cadherin 23, usu-
ally associated with Usher syndrome type 1D (USH1D; 
MIM601067) [5]. In contrast, hypo-functional mis-
sense mutations result in nonsyndromic hearing loss, 
preserving retinal and vestibular functions (DFNB12; 
MIM601386) [5, 10]. When these hypofunctional 
(DFNB12 allele) and nonfunctional mutations (USH1D 
allele) are in trans configuration to each other, it is pre-
sumed that the residual function of the DFNB12 allele 
preserves vision and the vestibular function, and impacts 
the function of only hair cells in the inner ear, resulting in 
the DFNB12 phenotype [11, 12]. To date, more than 50 
mutations have been identified in USH1D patients, and 
over 24 mutations in DFNB12 patients [13].
The advent of NGS rapidly led to identification of 
CDH23 as a cause of deafness, especially in East Asians. 
Indeed, CDH23 mutations contributed significantly to 
SNHL, with genetic loads that differed according to the 
ethnicity of the population [10, 14–16]. In East Asians, 
CDH23 mutations were the third-most frequent after 
GJB2 and SLC26A4. They accounted for 3.7  % of total 
hearing loss patients and 5.7  % of autosomal recessive 
SNHL (arSNHL) patients in Japan [13]. Recently, Park 
et al. [17] reported an association between CDH23 muta-
tions in hearing loss in 3 (3.22  %) of 93 Korean coch-
lear implantees with varying degrees of onset, and with 
diverse inheritance patterns [17]. Another small Korean 
cohort also had CDH23 mutations (2/13 [15 %]) resulting 
in autosomal recessive hearing loss with negative GJB2 
and SLC26A4 mutations [18]. Most of the patients had 
progressive, moderate-to-profound, high-tone hearing 
loss with some residual hearing in the lower frequencies, 
without vestibular or retinal dysfunction [12, 19].
Rigorous and costly bioinformatic analyses are needed 
to screen for these mutations, and despite significant 
reductions in the cost of some NGS techniques, rou-
tine clinical screening for CDH23 remains expensive 
and not cost-effective. Nevertheless, p.P240L, a pre-
dominant CDH23 mutation in Japanese and Koreans, is 
of interest as it accounts for ~43.3 % and >50 % of total 
CDH23 mutations, respectively [13, 18, 19]. The presence 
of a predominant allele would facilitate identification of 
DFNB12 subjects. However, whether p.P240L is a hot-
spot mutation, a founder mutation, or both, remains to 
be determined.
In this study, the relative genetic contribution of the 
CDH23 mutation to nonsyndromic arSNHL was esti-
mated in a Korean pediatric hearing loss cohort, and 
the genetic load of GJB2 and SLC26A4 was documented. 
Moreover, whether p.P240L, the most common CDH23 
mutation in Koreans, represented a common disease-
associated founder mutation was investigated. The clini-
cal characteristics (onset of hearing loss, progression, 
audiologic evaluation) of the hearing-impaired subjects 
carrying CDH23 mutations were also documented.
Methods
Ethical considerations
This study was approved by the Institutional Review 
Boards (IRBs) at the Seoul National University Bun-
dang Hospital (SNUBH) (IRB-B-1007-105-402) and 
the Seoul National University Hospital (SNUH) (IRBY-
H-0905-041-281). Written informed consent was 
obtained from all participating subjects. In case of the 
children, written informed consent was obtained from 
their parents or guardians on their behalf.
Study participants and audiometric evaluation
A total of 438 subjects who visited hereditary hearing loss 
clinics of tertiary referral centers: (SNUH and SNUBH) 
for their SNHL from September 2010 to October 2014 
were initially enrolled in this study. Clinical evaluations 
were performed in this cohort, including gender, date of 
birth, medical history, physical examination, pure tone 
audiometry and when available, imaging studies (tempo-
ral bone computed tomography or magnetic resonance 
imaging).
All of the enrolled subjects underwent an audiologic 
evaluation. The pure-tone thresholds were recorded at 
0.25, 0.5, 1, 2, 4 and 8 kHz. However, some infants could 
be recorded at only limited frequencies due to poor 
cooperation. The hearing threshold was calculated by 
averaging the thresholds of 0.5, 1, 2 and 4 kHz, and was 
classified as subtle (16–25 dB), mild (26–40 dB), moder-
ate (41–70 dB), severe (71–95 dB), or profound (>95 dB).
Based on the results of the above clinical and audio-
logic evaluations, pediatric subjects with prelingual 
onset, severe-to-profound SNHL segregating either in a 
sporadic or an autosomal recessive fashion were selected 
for this study. Individuals with unilateral or phenotypic 
markers in the inner ear structure, such as an incomplete 
partition type III, were excluded. However, subjects with 
an enlarged vestibular aqueduct (EVA) were included to 
compare the CDH23 mutation frequency with those of 
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mutations in SLC26A4 and other deafness genes in the 
same cohort (Fig.  1). Consequently, 128 unrelated chil-
dren with seemingly nonsyndromic severe-to-profound 
sporadic, or arSNHL without other notable abnormality 
were finally included in this study. All recruited subjects 
were Korean.
We recruited two control groups: the control group I 
included randomly chosen 40 Korean adult subjects with 
Fig. 1 A diagnostic flow chart of the enrolled subjects. Of a total of 438 subjects with various onset and degree of sensorineural hearing loss (SNHL) 
diagnosed from 2010 to 2014 at SNUH or SNUBH, 128 with the prelingual onset of a severe‑to‑profound degree of hearing loss, and with an auto‑
somal recessive (AR) or sporadic hereditary pattern were included in this study. The 310 subjects either with pre‑lingual mild to moderate degree 
SNHL or with post‑lingual SNHL subjects are excluded from the present study. SLC26A4 and/or GJB2 were sequenced, and the p.P240L of CDH23 
was screened in subjects without SLC26A4 or GJB2 mutations. One of the subjects (SB166‑208) with post‑lingual SNHL identified to carry p.P240L of 
CDH23 is included in the STR marker genotyping analysis. Next, targeted resequencing (TRS) of the 80˗204 known deafness genes was performed. 
Asterisks indicates MYO15A compound heterozygotes; SB77‑133, SH10‑28, SHJ23, dagger indicates MYO7A compound heterozygotes; SH156‑272, 
SH91‑202, SB71‑123. Control group I (272 subjects) was assigned for p.P240L mutation screening and control group II (40 subjects) was assigned for 
STR genotyping. All control groups showed normal hearing.
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pure tone audiograms indicating normal hearing thresh-
olds and the control group II comprised independent 
272 adult subjects with available whole exome sequenc-
ing data and with allegedly normal hearing. In this con-
trol group II, whole exome sequencing was performed 
prior to this study to make a molecular diagnosis of dis-
eases irrelevant to SNHL and their hearing status was 
evaluated by the interview. The control group I and II 
was recruited for the analysis on the haplotypes around 
p.P240 of CDH23 and calculation of the normal carrier 
frequency of p.P240L, respectively.
DNA samples and mutation analysis
Molecular genetic studies were conducted in 128 
probands and their family members. Genomic DNA was 
extracted from peripheral blood using standard protocols 
(Gentra Puregene Blood Kit, Qiagen, cat. 158389; Venlo, 
Limburg, Netherlands). The nonsyndromic prelingual 
arSNHL subjects with an enlarged vestibular aqueduct 
(EVA) underwent direct PCR-based Sanger sequencing 
of SLC26A4. Sanger sequencing of GJB2, 3 and 6 was per-
formed on subjects without noticeable phenotypic mark-
ers, as described previously [20] (Fig. 1).
Non-EVA samples that were also negative for muta-
tions in connexins GJB2, GJB3, and GJB6 were sub-
ject to Sanger sequencing of p.P240L, which was the 
most frequent mutant allele of CDH23 in Korean coch-
lear implantees, as reported in our previous study [17] 
(Fig.  1). The primer sequence for Sanger sequenc-
ing to screen p.P240L of CDH23 was CDH23-8F(5′-
CCACCATCACTCAACCTAAG-3′) and CDH23-8R 
(5′-ACTAACAGGGCCCATCCCTA-3). Next, targeted 
resequencing of 80, 129 (in collaboration with Otogenet-
ics (Norcross, GA, USA) or 200 known deafness genes 
[17] including CDH23, was performed on the remain-
ing non-EVA samples without a conclusive molecular 
diagnosis after sequencing of GJB2, GJB3, and GJB6, as 
described previously [17, 21], with the exception of those 
samples in which homozygous p.P240L mutations were 
detected at the screening of p.P240L by Sanger sequenc-
ing (Fig. 1). An additional file shows the supplementary 
lists of the genes included in the three targeted panels 
(see Additional file  1). This process identified DFNB12 
children carrying two probable pathogenic CDH23 vari-
ants in a trans configuration.
STR marker genotyping
The haplotype of the p.P240L allele of CDH23 in Kore-
ans was determined to ascertain whether the mutant 
allele was a common founder. For this purpose, we 
chose four STR markers flanking the CDH23 gene 
(Fig.  2a) which included two markers (D10S1650 and 
D10S1694) previously reported to be hypervariable 
and informative [5, 11]. Primers for four STR mark-
ers flanking the CDH23 gene were generated based 
on the UCSC Genome Browser as described [21]. The 







[5, 11]. Loci were amplified using AmpliTaq DNA poly-
merase (Invitrogen Life Technologies, Carlsbad, CA, 
USA) in a Perkin Elmer 9700 thermal cycler (Perkin 
Elmer, Waltham, MA, USA). The genotypes of these loci 
on 10 chromosomes were defined using an AmpliTaq 
gold (Applied Biosystems, Waltham, MA, USA) touch-
down protocol under the following conditions: 10 min at 
95 °C; 10 cycles of 30 s at 94 °C, 30 s at 65 °C, and 30 s at 
72 °C; and a further 20 cycles under the same conditions 
but with an annealing temperature lowered from 0.5 to 
55  °C, 15 cycles of annealing at 55  °C, and a 72  °C final 
extension for 10  min. STR marker genotyping was per-
formed as described previously [22].
One multiplex family (SB116) with co-segregating 
post-lingual onset of SNHL and a heterozygous p.P240L 
mutant allele of CDH23 was also included in this analy-
sis. STR marker analyses were conducted in 11 subjects 
from five SNHL families (four prelingual and one post-
lingual) in total, segregating p.P240L of CDH23, and also 
in 40 adult Korean subjects with documented normal 
hearing thresholds.
Statistical analysis
The allele frequency of p.P240L was compared between 
prelingually onset, severe-to-profound sporadic/auto-
somal recessive SNHL in a pediatric population and 272 
normal hearing controls (control group II). Differences 
in STR genotypes and the distribution of haplotypes 
between mutant chromosomes carrying p.P240L and 80 
wild-type Korean chromosomes from 40 normal-hearing 
subjects (control group I) were analyzed by Fisher’s exact 
test. One postlingual adult DFNB12 subject (SB116-208) 
was additionally included for the STR genotyping, while 
the subject was excluded for calculation of the allele fre-
quency of p.P240L among pediatric prelingual severe to 
profound SNHL. Contributions of some genotypes were 
compared among subjects, but not between chromo-
somes, due to the lack of parental samples, as described 
previously [17, 23]. Especially, haplotypes of normal con-
trols were constructed in a conservative way that was 
toward minimizing the statistical difference of haplotypes 
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between p.P240L carriers with SNHL and normal 
controls.
Statistical analyses were performed using SPSS 18.0 
(SPSS Inc., Chicago, USA). The level of statistical signifi-
cance was defined as a p value of <0.05.
Results
The contribution of mutations in CDH23 to profound 
nonsyndromic arSNHL in Korean children
Among 128 children with prelingual onset, nonsyndro-
mic, sporadic or autosomal recessive, severe-to-profound 
Fig. 2 a Location of p.P240L of CDH23 and 4 STR markers linked to the p.P240L mutation on chromosome 10q22.1. Four STR makers were located 
in the flanking regions of the CDH23 gene. The D10S1650 and D10S1694 were previously reported STR markers to be hypervariable and informative. 
b Pedigrees showing the segregation of the p.P240L mutation and the four STR marker haplotypes. Haplotypes for STR markers linked to p.P240L 
from five probands (black arrow) are indicated in bold in either open or shaded boxes). A single haplotype for four STR markers (D10S584, D10S1650, 
D10S606, and D10S1694) is definitely shared by four alleles linked to p.P240L (shaded box) including one allele from a postlingual‑hearing‑loss adult 
(SB116‑208), indicative of a very strong founder allele in Koreans. The single common haplotype can be potentially assigned to two of three alleles 
(open box) carrying p.P240L from two subjects (SB56‑103 and SH97‑211. Definite haplotypes could be assigned based on information from parental 
samples or affected siblings in SH164‑359, SH59‑133, and SB116‑208. Despite a lack of parental or sibling samples, a most‑likely probable haplotype 
could be assigned based on the haplotypes of other subjects carrying p.P240L in SB56‑103 and SH97‑211.
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SNHL, 22 (17.2  %) had two mutant alleles of GJB2 
(DFNB1) and 23 (18.0  %) carried two mutant alleles of 
SLC26A4 (DFNB4). The detection frequency of CDH23 
mutations (SH 59-133 [17], SH 164-359 [17], SB56-
103 and SH 97-211) in our pediatric cohort was 4/128 
(3.1 %), which was slightly higher than the 3/128 (2.3 %) 
and 3/128 (2.3 %) of MYO15A and MYO7A, respectively, 
in the same cohort. Considering the fact that we did not 
screen CDH23 from 22 subjects with two mutant alleles 
of GJB2, the actual frequency of CDH23 might be even 
slightly high than this figure. Our result showed that 
CDH23 was one of the leading causes of prelingual-onset 
profound nonsyndromic arSNHL in children and was a 
component of the suite of genes that includes SLC26A4 
and GJB2, in the Korean pediatric cohort (Fig.  1). The 
mean age at detection of hearing loss was 2.25 years, with 
a range of 1–4 years. All four subjects with CDH23 muta-
tions showed a similar phenotype and prelingual pro-
found hearing loss with minimal residual hearing (Fig. 3). 
None of the four CDH23 carriers exhibited symptoms of 
nyctalopia, and ophthalmologic examinations revealed 
no definite abnormalities.
The p.P240L mutant allele of CDH23 predominated in the 
pediatric cohort
Interestingly, all four subjects carried p.P240L as either a 
homozygote or compound heterozygotes, suggesting that 
this mutant allele was either a strong common founder or 
a mutational hotspot in this population (Table 1) (Fig. 3).
To ascertain whether p.P240L was a causative variant 
in these subjects, the carrier frequency of the p.P240L 
allele was calculated among 272 adult controls with alleg-
edly normal hearing thresholds (control group II). None 
of the normal control subjects carried the mutant allele, 
which further confirmed its pathogenic potential (6/256 
vs 0/544, p = .001, by Fischer’s exact test) (Table 2).
The rate of concordance in STR markers linked to the 
p.P240L mutation
p.P240L was assumed to act as a common founder muta-
tion or a mutational hot spot. To ascertain whether 
p.P240L was a common founder, p.P240L-linked hap-
lotypes of four STR markers (D10S584, D10S1650, 
D10S606, and D10S1694) were constructed and analyzed 
in five unrelated probands from five families (four prelin-
gual [SH 59, SH164, SB56, and SH97] and one postlin-
gual [SB116]), and in 40 adult Korean normal-hearing 
subjects (control group I) (Table  3; Fig.  2b). For two 
pediatric probands (SH164-359 and SH59-133) and one 
adult proband (SB116-208), haplotypes could definitely 
be assigned, based on information from the parents and 
affected siblings (Fig. 2b). For the remaining two pediatric 
probands (SH56-103 and SH97-211), precise haplotypes 
could not be assigned due to a lack of parental or sibling 
samples. Instead, their most likely probable haplotype 
was inferred from the other p.P240L-carrying subjects 
in our cohort (Fig. 2b). In detail, our three p.P240L-car-
rying probands (SH164-359, SH59-133, and SB116-208) 
with definitive STR haplotypes shared a common single 
haplotype (shaded box in Fig. 2b) in their all four alleles 
linked to p.P240L. Based on this, the other two subjects 
(SB56-103 and SH97-211) were also assumed to have 
this common haplotype (Fig.  2b). However, these two 
subjects (SB56-103 and SH97-211) might have a differ-
ent haplotype linked to p.P240L against our assumption. 
Nonetheless, at least four (57.1 %) (shaded box in Fig. 2b) 
(two alleles from SH164-359, and each allele from SH59-
133 and SB116-208) of the seven p.P240L-linked alleles 
(shaded or open box in Fig. 2b) showed identical haplo-
types (Fig. 2b). In contrast, the normal controls showed 
diverse haplotypes for these STR markers, and the iden-
tical haplotype present in the p.P240L carriers could 
not be assigned to any of the normal controls (0/80) 
(Table  3). Consequently, p.P240L was significantly asso-
ciated with a single haplotype in our cohort even under 
a conservative setting where SH56-103 and SH97-211 
were assumed to have a different haplotype (57.1 % [4/7] 
vs. 0 % [0/80], p < .0001 by Fisher’s exact test). However, 
the identical haplotype could be inferred also in two sub-
jects (SH56-103 and SH97-211) without any additional 
samples from their families by assuming the most likely 
haplotype, making the proportion of shared identical 
haplotypes 85.7  % (6/7). Conversely, when only three 
STR markers were considered (D10S584, D10S1650, and 
D10S606), seven alleles from the normal controls (8.75 %, 
7/80) could potentially be matched to an identical hap-
lotype that was strongly associated with p.P240L. Even 
under this assumption, a highly significant statistical 
association was detected between p.P240L and a single 
haplotype (p < .001 by Fisher’s exact test) (Table 3).
Discussion
The prevalence of recessive CDH23 mutations in our 
pediatric cohort with severe-to-profound nonsyndro-
mic arSNHL was 3.1 %. This was in agreement with find-
ings for CDH23 variants in other studies on East Asian 
populations, the prevalences of which ranged from 1.6 
to 15.4 %, using cohorts with nonsyndromic arSNHL not 
necessarily limited to prelingual pediatric deaf subjects 
(Table 2) [18, 19, 24, 25]. The wide range in the frequency 
from 1.6 to 15.4 % may be attributed to ethnicity differ-
ences among East Asians. Alternatively, an intrinsic dif-
ference in the study cohort, such as cohort size or onset 
age of SNHL, could also account for these differences. In 
this study, the cohort consisted exclusively of prelingual 
nonsyndromic arSNHL pediatric subjects. Therefore, 
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Fig. 3 Pedigrees and audiograms of the subjects carrying the CDH23 mutation. All four carriers of p.P240L in CDH23 showed severe‑to‑profound 
autosomal recessive prelingual SNHL (arSNHL) with minimal residual hearing.
Table 1 Mutations of the CDH23 gene identified in this study
a NM_022124.
b NP_071407.
Patient Sex/age Classification Nucleotide changea Amino acid changeb Inheritance pattern
SH59‑133 F/3 Children c.C719T; c.C4853A p.P240L; p.T1618K Compound heterozygote
SH97‑211 F/1 Children c.C719T p.P240L Homozygote
SH164‑359 F/1 Children c.C719T p.P240L Homozygote
SB56‑103 F/4 Children c.C719T; c.8574delC p.P240L;p.Asp2858GlufsX8 Compound heterozygote
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Table 2 Prevalence of CDH23 mutations in East Asian
AR autosomal recessive inheritance.
a The prevalence of CDH23 mutations when excluding the subjects with GJB2 or SLC26A4 mutations.
b The prevalence of CDH23 mutations with 10 homozygote, 13 compound heterozygote, excluding single heterozygote cases, 29 heterozygote.
c The prevalence of CDH23 mutations with 10 homozygote, 13 compound heterozygote.
d The prevalence of CDH23 mutations in autosomal recessive subjects, excluding sporadic cases.
Characteristics Study1 Study2 Study3,4
Ethnicity Korean Korean Japan
Onset of hearing loss Prelingual Early onset Pre & postlingual
Inheritance AR, or sporadic AR AR, or sporadic
Degree of hearing loss Severe‑to‑profound Severe‑to‑profound Various
Syndromic/nonsyndromic Nonsyndromic Nonsyndromic
No GJB2 and SLC26A4 mutations
Nonsyndromic
Frequency of CDH23 mutations 3.13 (4/128)
4.82 (4/83)a
15.38 (2/13) 3.72 (52/1396)b
(33, postlingual, 19, prelingual)
1.6 (23/1396)c
2.5 (23/919)d
Frequency of p.P240L alleles
 Affected 2.34 (6/256) 7.69 (2/26) 1.61 (45/2792)
 Control 0 (0/544) 0.12 (2/1636) 0.26 (1/384)
 Affected (in CDH23 mutations) 85.71 (6/8) 50.00 (2/4) 60.01 (45/2792)
References This study [18] [19]
[24] 
Table 3 Chromosome 10q22.1 STR haplotypes linked to p.P240L of CDH23
* Meiotic phase and chromosomes in SH56-103 and SH97-211(SHJ71) and in most of the normal hearing controls could not be decisively assigned due to lack of 
parental DNA samples: In these cases, genotype contributions were compared among subjects, not chromosomes as described [23] (p > 0.001 by Fisher exact test). 
Haplotypes of normal controls were constructed in a conservative way where the haplotype closest to the haplotype 1 (see above) was preferentially assumed from 
STR genotyping data. **The number in parenthesis indicates a genotype contribution among chromosomes confirmed through checking parental samples (p > 0.001 
by Fisher exact test).
Haplotype STR marker genotype Korean chromosome
D10S584 D10S1650 D10S606 D10S1694 P240L (n = 7) Control (n = 80)
1 184 138 238 149 6* (4)** 0**
2 184 138 236 155 1 0
3 182 136 230 139 0 4
4 184 138 238 147 0 2*
5 184 138 238 145 0 2*
6 184 138 230 139 0 2
7 184 138 234 141 0 2
8 184 134 238 147 0 2
9 184 136 238 139 0 2
10 184 134 234 147 0 2
11 184 130 230 139 0 2
12 190 134 234 147 0 2
13 184 138 238 139 0 1*
14 184 138 238 141 0 1*
15 184 138 238 153 0 1*
16 184 138 240 149 0 1
17 184 138 232 145 0 1
18 184 138 236 147 0 1
19 184 138 236 145 0 1
20–69 – – – – 0 51
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significantly higher frequency of CDH23 mutations (15.4 
vs 3.1  %) obtained from a different Korean cohort with 
nonsyndromic arSNHL not limited to prelingual SNHL 
cases [18] (Table 2) may suggest CDH23 mutations also 
significantly contribute to adult-onset postlingual arS-
NHL in Koreans. Indeed, in contrast to the p.P240L 
mutation, which presented mostly as prelingual severe-
to-profound hearing loss, certain CDH23 mutations, 
such as p.R2029W and p.T1368M, were reported to be 
associated with postlingual onset of moderate hearing 
loss, and most CDH23-affected subjects showed pro-
gressive hearing loss [13]. These results warrant further 
investigation in a separate study.
CDH23 mutations were the third-most prevalent 
molecular etiology in the pediatric prelingual arSNHL 
cohort, after SLC26A4 and GJB2, which accounted for 
18.0 and 17.2  %, respectively. A mutation of p.P240L in 
CDH23 was detected in all four DFNB12 subjects, as 
either a compound heterozygote or a homozygote, in the 
Korean cohort. Screening of p.P240L alone significantly 
facilitated detection of DFNB12 or DFNB12 candidates 
in Korean subjects, despite the large size of this gene. 
Given the prevalence of p.P240L, incorporation of a test 
for p.P240L in CDH23 as a next step in GJB2 sequencing 
in non-EVA subjects would be cost-effective (Fig. 1).
Indeed, several studies have reported the predomi-
nance of the p.P240L mutation in Japanese and Korean 
populations affected by the prelingual or postlingual arS-
NHL [18, 19, 24]. In line with these studies, our results 
showed that 85.7  % (6/8) of the alleles of the CDH23 
mutation carriers in the Korean pediatric population had 
p.P240L (Table 2). Based on the frequency of this variant, 
we hypothesized that p.P240L of CDH23 had a founder 
effect in East Asians. Based on our haplotype analyses, 
p.P240L was mainly carried on a single common haplo-
type and the common haplotype linked to p.P240L was 
not detected at all in normal controls, indicating that 
the p.P240L mutation arose from a common founder in 
Koreans.
This is the first documented evidence for the founder 
mutation hypothesis of p.P240L of CDH23. Previous 
studies on CDH23 mutations in Caucasian populations 
did not show clear founder mutations due to the het-
erogeneous ethnicities of these populations [5, 6, 11, 
14]. Instead, most of the CDH23 variants from different 
ethnic backgrounds were assumed to be private [26, 27]. 
Several reports identified founder effects of frequently 
encountered mutations in specific ethnic populations. 
Regarding mutations in GJB2, several studies reported 
the frequency of 235delC among East Asians [22], 35delG 
in the Caucasians [28], and 167delT in Ashkenazi Jews 
[29], suggesting that these were the result of a founder 
effect, rather than a mutational hot spot. The most 
common deafness gene in our cohort, SLC26A4, con-
tained the H723R and IVS7-2A>G founder mutations, 
which are unique to East Asians [30]. The p.A306 muta-
tion of TMPRSS3 was also recently reported to possess a 
founder role in Koreans [23].
Most CDH23 missense mutations localized in the 
calcium-binding sequences were associated with non-
syndromic hearing loss, which was presumed to be 
attributable to the increased sensitivity of the cochlear 
function to calcium-dependent cell adhesion, compared 
to that of the retinal function [15]. p.P240L is a mis-
sense mutation that affects a residue localized in the 
EC3 domain, with the highly conserved calcium-binding 
motifs, and therefore does not interfere with calcium 
binding. Instead, the change from the rigid cyclic side 
chain of proline to a longer and more flexible leucine 
residue, results in instability in the structure and function 
of the protein [18]. To date, the functional defects caused 
by the p.P240L mutation have not been determined 
in vitro or in vivo. However, this mutation has been iden-
tified only in subjects with nonsyndromic hearing loss 
(DFNB12) [13, 18, 19]. Furthermore, based solely on a 
previous audiologic phenotypic study, p.P240L carriers 
usually show congenital and more severe SNHL than do 
carriers of other missense mutations in CDH23 [13]. In 
accordance with this finding, the four pediatric subjects 
in this study with p.P240L showed prelingual and severe-
to-profound nonsyndromic SNHL with minimal residual 
hearing at all frequencies.
The p.P240L allele can be classified as a DFNB12 allele, 
rather than an USH1D allele, based on a previous hypoth-
esis [11] and the phenotype of p.P240L carriers in East 
Asian populations [13, 18, 19]. The higher prevalence of 
this DFNB12 allele of p.P240L compared to other CDH23 
mutant alleles implies that in Koreans the nonsyndromic 
hearing loss (DFNB12) phenotype is more commonly 
associated with CDH23 mutations than is the syndromic 
hearing loss phenotype (USH1D).
The geographic or ethnic spectra of founder muta-
tions vary, and whether the most frequent mutation allele 
represents a founder mutation and/or a mutational hot 
spot is often unclear. Some founder mutations have a 
narrow distribution; for example, due to the practice of 
consanguineous marriage, the high prevalence of GJB2 
mutations in some Western cultures can be attributed 
to a single ancestor mutation [31]. On the other hand, 
the p.A306T mutation of TMPRSS3 affects a wide eth-
nic spectrum, encompassing East Asians and Euro-
peans, and hence is predicted to be a mutational hot 
spot [23, 32, 33]. However, the distribution of several 
founder alleles, such as the 235delC mutation of GJB2 
and the H723R and IVS7-2A>G mutations of SLC26A4, 
is restricted to East Asians [22, 30]. Only a single cohort 
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of Koreans was investigated in this study, a high preva-
lence of the p.P240L mutation in East Asians has been 
reported by others [13, 18, 19, 34], whereas this muta-
tion was rarely reported in other ethnic groups [5, 6, 14]. 
Therefore, p.P240L is likely a founder mutation exclusive 
to East Asians. Information on the distinct distribution 
pattern of the deafness mutations may facilitate deter-
mination of the phylogenetic evolution of the deafness 
genes. Although its value would be limited due to a lack 
of data on Mongolian or other Asian populations, the 
different frequency of the p.P240L mutation between 
East Asian populations and other ethnicities suggests 
that the p.P240L mutation occurred sometime after the 
divergence of several ethnic groups from Central or East 
Asia ~40,000  years ago [35, 36]. Further studies using 
other genetic polymorphisms, such as single-nucleotide 
polymorphisms (SNPs) and STR markers adjacent to 
the p.P240L mutation, would enable a more accurate 
estimate of the age of this mutation. Further data on the 
prevalence of CDH23 mutations and the haplotypes in 
other ethnic groups would enable tracing of the common 
ancestor or route of divergence of the CDH23 mutation. 
This information would have phylogenetic applications.
Conclusion
The genetic load of CDH23 mutations in Korean children 
with prelingual onset, nonsyndromic, sporadic or auto-
somal recessive, severe-to-profound SNHL was 3.1  %. 
p.P240L was the most common CDH23 mutation. Geno-
typing of STR markers linked to p.P240L showed that the 
p.P240L mutation had a strong founder effect in Koreans. 
This novel finding may facilitate genetic diagnosis of, and 
research into, CDH23 mutations, as well as provide infor-
mation for further phylogenetic studies.
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